- Home
- NVFY vs GOVX Comparison
NVFY vs GOVX Comparison
Compare NVFY & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVFY
- GOVX
- Stock Information
- Founded
- NVFY 2003
- GOVX 2001
- Country
- NVFY United States
- GOVX United States
- Employees
- NVFY N/A
- GOVX N/A
- Industry
- NVFY Home Furnishings
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- NVFY Consumer Discretionary
- GOVX Health Care
- Exchange
- NVFY Nasdaq
- GOVX Nasdaq
- Market Cap
- NVFY 14.3M
- GOVX 15.5M
- IPO Year
- NVFY N/A
- GOVX N/A
- Fundamental
- Price
- NVFY $1.22
- GOVX $1.12
- Analyst Decision
- NVFY
- GOVX Strong Buy
- Analyst Count
- NVFY 0
- GOVX 5
- Target Price
- NVFY N/A
- GOVX $12.40
- AVG Volume (30 Days)
- NVFY 36.5K
- GOVX 275.9K
- Earning Date
- NVFY 05-15-2025
- GOVX 08-05-2025
- Dividend Yield
- NVFY N/A
- GOVX N/A
- EPS Growth
- NVFY N/A
- GOVX N/A
- EPS
- NVFY N/A
- GOVX N/A
- Revenue
- NVFY $9,946,300.00
- GOVX $5,591,576.00
- Revenue This Year
- NVFY N/A
- GOVX N/A
- Revenue Next Year
- NVFY N/A
- GOVX N/A
- P/E Ratio
- NVFY N/A
- GOVX N/A
- Revenue Growth
- NVFY N/A
- GOVX N/A
- 52 Week Low
- NVFY $0.39
- GOVX $0.73
- 52 Week High
- NVFY $2.08
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- NVFY 55.19
- GOVX 58.57
- Support Level
- NVFY $0.91
- GOVX $1.00
- Resistance Level
- NVFY $1.22
- GOVX $1.14
- Average True Range (ATR)
- NVFY 0.19
- GOVX 0.07
- MACD
- NVFY -0.03
- GOVX 0.02
- Stochastic Oscillator
- NVFY 40.79
- GOVX 82.61
About NVFY Nova Lifestyle Inc.
Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.